节点文献

糖原合成酶激酶3β(GSK3β)参与调控视网膜疾病的研究进展

Research progress of glycogen synthase kinase 3 beta in the regulation of retinal diseases

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 刘晓晖徐静吴京

【Author】 LIU Xiaohui;XU Jing;WU Jing;Department of Ophthalmology,Nanfang Hospital,Southern Medical University;Huiqiao Medical Center,Nanfang Hospital,Southern Medical University;

【通讯作者】 吴京;

【机构】 南方医科大学南方医院眼科南方医科大学南方医院惠侨医疗中心

【摘要】 视网膜疾病是视力丧失的常见原因,近年来受到社会的广泛关注。视网膜细胞在受到氧化应激、衰老等内外环境的刺激时,经历一系列的病理改变从而发生功能障碍。在受损的视网膜细胞中,糖原合成酶激酶3β(GSK3β)的活性发生了改变,通过介导细胞凋亡、血管新生等多种效应参与调控视网膜疾病的发生发展,干预GSK3β调节通路治疗视网膜疾病具有潜在临床意义。本文就多种视网膜疾病中GSK3β的活性调节机制进行综述。

【Abstract】 Retinal disease is a common cause of vision loss and has received widespread attention in recent years. Retinal cells, when exposed to internal or external environmental stimuli such as oxidative stress and aging, will undergo a series of pathological changes and become dysfunctional. In the damaged retinal cells, glycogen synthase kinase 3 beta(GSK3β) is altered in activity and then regulates the development of retinal diseases by mediating apoptosis and angiogenesis. Regulation of GSK3β pathways has potential clinical significance in treating retinal diseases. This article reviews the regulation mechanisms of GSK3β activity in various retinal diseases.

【基金】 广东省科技计划项目(编号:2017A020211005);广州市科技计划项目(编号:202102020527);南方医科大学南方医院院长基金(编号:2020C008)
  • 【文献出处】 眼科新进展 ,Recent Advances in Ophthalmology , 编辑部邮箱 ,2022年02期
  • 【分类号】R774.1
  • 【被引频次】1
  • 【下载频次】180
节点文献中: 

本文链接的文献网络图示:

本文的引文网络